Anxiety Clinical Trials May Not Provide Representative Sample
the Psychiatry Advisor take:
Pharmacological and pharmacotherapy clinical trials may not yield representative results as too many patients are excluded from the studies.
Nicholas Hoertel, MD, MPH, of the French Institute of Health and Medical Research in Paris, and colleagues, examined data from the 2004-2005 National Epidemiologic Survey on Alcohol and Related Conditions, which includes more than 34,000 adults. Their goal was to assess how many participants with social anxiety disorder (SAD) would fulfill typical eligibility criteria.
More than seven of 10 respondents from the overall SAD sample in a typical pharmacological efficacy trial and more than six of 10 participants in a typical psychotherapy efficacy trial would have been excluded by at least one criterion, the researchers reported in the Journal of Clinical Psychopharmacology. Most of the ineligibility was related to participants having depression.
Also, more than 80% of respondents seeking treatment for SAD would have been excluded from participation in a typical pharmacological or psychotherapy efficacy trial.
“Clinical trials should carefully consider the impact of exclusion criteria on the generalizability of their results and explain the rationale for their use,” the researchers concluded. “For SAD treatment trials to adequately inform clinical practice, the eligibility rate must be increased through a general relaxation of overly stringent eligibility criteria.”
Clinical Trials for Anxiety May Not Provide Representative Sample
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Correctional Psychiatry: Challenges and Rewards
- Color Vision Impairment in Schizophrenia May Be Due to Medication
- Sleep Disorders Linked to Nonaffective Psychosis in Young Adults
- Lithium May Treat Children With Bipolar Disorder, but Pediatric Studies Are Lacking
- Improvement in Guidelines for Monitoring Patients Receiving Lithium Essential
- The Opioid System: The Foundation for Social Risk and Reward
- Nomophobia: The Modern-Day Pathology
- Is Mandatory Reporting of Child Maltreatment in the Best Interests of the Child?
- Emerging Theories in the Pathophysiology of MDD: Could the Opioid System Be Involved?
- The Impact of Deafness on Hallucinations and Delusions
- Associations Among Gender Nonconformity, Mental Distress, and Substance Use Among High School Students
- Digital Cognitive Therapy Eases Daytime Effects of Insomnia
- Predicting Poststroke Depression: Biomarkers and Beyond
- Sexual Harassment, Assault Tied to Women's Health Issues
- Daily Drinking Associated With Increased Mortality Risk